Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Dec 12, 2016 $1.61 $1.62 $1.59 $1.62 28 799
Dec 09, 2016 $1.65 $1.68 $1.60 $1.61 12 218
Dec 08, 2016 $1.60 $1.63 $1.60 $1.60 16 482
Dec 07, 2016 $1.72 $1.77 $1.58 $1.60 72 849
Dec 06, 2016 $1.58 $1.77 $1.58 $1.73 68 946
Dec 05, 2016 $1.61 $1.63 $1.54 $1.62 49 377
Dec 02, 2016 $1.60 $1.63 $1.57 $1.60 6 410
Dec 01, 2016 $1.59 $1.65 $1.57 $1.59 12 384
Nov 30, 2016 $1.69 $1.69 $1.58 $1.60 52 537
Nov 29, 2016 $1.62 $1.96 $1.56 $1.61 363 472
Nov 28, 2016 $1.61 $1.66 $1.55 $1.60 45 026
Nov 25, 2016 $1.57 $1.64 $1.56 $1.58 2 096
Nov 23, 2016 $1.62 $1.62 $1.54 $1.58 36 362
Nov 22, 2016 $1.56 $1.68 $1.53 $1.62 118 718
Nov 21, 2016 $1.69 $1.70 $1.56 $1.56 60 390
Nov 18, 2016 $1.67 $1.69 $1.59 $1.69 25 261
Nov 17, 2016 $1.63 $1.71 $1.62 $1.65 82 871
Nov 16, 2016 $1.70 $1.75 $1.55 $1.66 178 852
Nov 15, 2016 $1.59 $1.71 $1.52 $1.67 286 071
Nov 14, 2016 $1.56 $1.64 $1.53 $1.56 81 631
Nov 11, 2016 $1.55 $1.62 $1.53 $1.53 10 629
Nov 10, 2016 $1.53 $1.62 $1.53 $1.55 37 889
Nov 09, 2016 $1.52 $1.56 $1.51 $1.55 12 792
Nov 08, 2016 $1.50 $1.55 $1.50 $1.53 19 620
Nov 07, 2016 $1.50 $1.53 $1.47 $1.49 7 000
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT